Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2202-2214

  Jansen, Felix ^a   Yang, Xiaoyan ^b   Baumann, Katharina ^a   Przybilla, David ^a   Schmitz, Theresa ^a   Flender, Anna ^a   Paul, Kathrin ^a   Alhusseiny, Adil ^a   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Endothelial microparticles; ICAM 1; Inflammation; MicroRNA 222

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MICRORNA 222; ANTIINFLAMMATORY AGENT; GLUCOSE; MICRORNA; MIRN222 MICRORNA, HUMAN; MIRN222 MICRORNA, MOUSE; TUMOR NECROSIS FACTOR;

AGED; ANGIOCARDIOGRAPHY; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DESCENDING AORTA; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULITIS; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; BLOOD; C57BL MOUSE; CELL ADHESION; CELL LINE; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; GENETICS; INFLAMMATION; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION; CELL LINE; CELL-DERIVED MICROPARTICLES; CORONARY ARTERY DISEASE; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; GLUCOSE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICE, INBRED C57BL; MICRORNAS; MIDDLE AGED; MODELS, BIOLOGICAL; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940796521     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12607     Document Type: Article

References (39)

1. Libby P. Changing concepts of atherogenesis. J Intern Med. 2000; 247: 349-58.
2. Rautou P-E, Vion A-C, Amabile N, et al. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011; 109: 593-606.
3. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010; 107: 1047-57.
4. Leroyer AS, Anfosso F, Lacroix R, et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb Haemost. 2010; 104: 456-63.
5. Sabatier F, Roux V, Anfosso F, et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood. 2002; 99: 3962-70.
6. Abid Hussein MN, Böing AN, Biró E, et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res. 2008; 121: 865-71.
7. Pérez-Casal M, Downey C, Cutillas-Moreno B, et al. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica. 2009; 94: 387-94.
8. Nomura S. Statin and endothelial cell-derived microparticles. Thromb Haemost. 2008; 100: 377-8.
9. Jansen F, Yang X, Hoyer FF, et al. Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. Arterioscler Thromb Vasc Biol. 2012; 32: 1925-35.
10. Jansen F, Yang X, Hoelscher M, et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 2013; 128: 2026-38.
11. Federici M, Menghini R, Mauriello A, et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation. 2002; 106: 466-72.
12. Fang F, Yang Y, Yuan Z, et al. Myocardin-related transcription factor A mediates OxLDL-induced endothelial injury. Circ Res. 2011; 108: 797-807.
13. Boon RA, Vickers KC. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol. 2013; 33: 186-92.
14. Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010; 107: 677-84.
15. Wahl P, Jansen F, Achtzehn S, et al. Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors. PLoS ONE. 2014; 9: e96024.
16. Diehl P, Fricke A, Sander L, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res. 2012; 93: 633-44.
17. Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012; 82: 412-27.
18. Jansen F, Yang X, Proebsting S, et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014; 3: e001249.
19. Leroyer AS, Tedgui A, Boulanger CM. Microparticles and type 2 diabetes. Diabetes Metab. 2008; 34: S27-32.
20. Tsimerman G, Roguin A, Bachar A, et al. Involvement of microparticles in diabetic vascular complications. Thromb Haemost. 2011; 106: 310-21.
21. Hoyer FF, Nickenig G, Werner N. Microparticles - messengers of biological information. J Cell Mol Med. 2010; 14: 2250-6.
22. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009; 2: ra81.
23. Jansen F, Yang X, Hoyer FF, et al. Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. Arterioscler Thromb Vasc Biol. 2012; 32: 1925-35.
24. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 2011; 31: 27-33.
25. Empana J-P, Boulanger CM, Tafflet M, et al. Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study. Eur Heart J Acute Cardiovasc Care. 2014; 4: 28-36.
26. Loyer X, Vion A-C, Tedgui A, et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res. 2014; 114: 345-53.
27. Mause SF, von Hundelshausen P, Zernecke A, et al. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol. 2005; 25: 1512-8.
28. Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010; 39: 133-44.
29. Hergenreider E, Heydt S, Tréguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012; 14: 249-56.
30. Ueda R, Kohanbash G, Sasaki K, et al. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci USA. 2009; 106: 10746-51.
31. Liu X, Cheng Y, Zhang S, et al. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009; 104: 476-87.
32. Dentelli P, Rosso A, Orso F, et al. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol. 2010; 30: 1562-8.
33. Liu X, Cheng Y, Yang J, et al. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol. 2011; 52: 245-55.
34. Jansen F, Yang X, Franklin BS, et al. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. Cardiovasc Res. 2013; 98: 94-106.
35. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010; 107: 810-7.
36. Li Q, Liu X, Yin Y, et al. Insulin regulates glucose consumption and lactate production through reactive oxygen species and pyruvate kinase M2. Oxid Med Cell Longev. 2014; 2014: 504953.
37. Togliatto G, Trombetta A, Dentelli P, et al. MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia. 2011; 54: 1930-40.
38. Rautou P-E, Leroyer AS, Ramkhelawon B, et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res. 2011; 108: 335-43.
39. Rautou P-E, Bresson J, Sainte-Marie Y, et al. Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology. 2012; 143: 166-76.e6.